Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4300
+0.0035 (0.82%)
At close: Jul 30, 2026, 4:00 PM EDT
0.4300
0.00 (0.00%)
After-hours: Jul 30, 2026, 4:10 PM EDT
Impact BioMedical Revenue
Impact BioMedical had revenue of $7.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $39.00K. In the year 2025, Impact BioMedical had annual revenue of $32.00K.
Revenue (ttm)
$39.00K
Revenue Growth
n/a
P/S Ratio
1,188.80
Revenue / Employee
$19,500
Employees
2
Market Cap
46.36M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 50.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Metagenomi Therapeutics | 22.33M |
| Immutep | 5.28M |
| BeyondSpring | 1.88M |
| RenovoRx | 1.49M |
| Seres Therapeutics | 1.15M |
| Mereo BioPharma Group | 500.00K |
| aTyr Pharma | 190.00K |
| INmune Bio | 50.00K |
IBO News
- 2 months ago - Impact BioMedical Quarterly report: Q1 2026 - Filings
- 4 months ago - Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans - GlobeNewsWire
- 5 months ago - Impact BioMedical Annual report: Q4 2025 - Filings
- 5 months ago - Why Is Impact BioMedical Stock (IBO) Up Today? - TipRanks
- 9 months ago - Impact BioMedical Quarterly report: Q3 2025 - Filings
- 11 months ago - Impact BioMedical Proxy statement: Proxy Filing - Filings
- 1 year ago - Impact BioMedical announces 3F U.S. patent issue - TheFly
- 1 year ago - Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - GlobeNewsWire